Role of NAD(+) in regulating cellular and metabolic signaling pathways.
Role of NAD(+) in regulating cellular and metabolic signaling pathways.
复制标题
DOI:
10.1016/j.molmet.2021.101195
复制
发表时间:
2021-07
影响因子:
8.1
通讯作者:
Bagga P
中科院分区:
文献类型:
--
作者:
Amjad S;Nisar S;Bhat AA;Shah AR;Frenneaux MP;Fakhro K;Haris M;Reddy R;Patay Z;Baur J;Bagga P
Nicotinamide adenine dinucleotide (NAD+), a critical coenzyme present in every living cell, is involved in a myriad of metabolic processes associated with cellular bioenergetics. For this reason, NAD+ is often studied in the context of aging, cancer, and neurodegenerative and metabolic disorders. Cellular NAD+ depletion is associated with compromised adaptive cellular stress responses, impaired neuronal plasticity, impaired DNA repair, and cellular senescence. Increasing evidence has shown the efficacy of boosting NAD+ levels using NAD+ precursors in various diseases. This review provides a comprehensive understanding into the role of NAD+ in aging and other pathologies and discusses potential therapeutic targets. An alteration in the NAD+/NADH ratio or the NAD+ pool size can lead to derailment of the biological system and contribute to various neurodegenerative disorders, aging, and tumorigenesis. Due to the varied distribution of NAD+/NADH in different locations within cells, the direct role of impaired NAD+-dependent processes in humans remains unestablished. In this regard, longitudinal studies are needed to quantify NAD+ and its related metabolites. Future research should focus on measuring the fluxes through pathways associated with NAD+ synthesis and degradation. NAD+ regulates energy metabolism, DNA damage repair, gene expression, and stress response. NAD+ deterioration contributes to the progression of multiple metabolic disorders, cancers, and neurodegenerative diseases. Nicotinamide mononucleotide and nicotinamide riboside raise NAD+ levels in different tissues in preclinical models. Imaging studies on genetic models can illustrate the pathways of NAD+metabolism and their downstream functional effects. Human clinical trials to determine benefits of restoration of NAD+ by using NAD precursors are in progress.
登录
查看更多内容
影响因子:
29
作者:
Chalkiadaki A;Guarente L
通讯作者:
Guarente L
影响因子:
--
作者:
Audrito, Valentina;Manago, Antonella;Deaglio, Silvia
通讯作者:
Deaglio, Silvia
影响因子:
10.5
作者:
Chen, Danica;Bruno, Joanne;Guarente, Leonard
通讯作者:
Guarente, Leonard
影响因子:
3.6
作者:
Bayrakdar, Ezgi Turunc;Armagan, Guliz;Yalcin, Ayfer
通讯作者:
Yalcin, Ayfer
影响因子:
2.9
作者:
Almeida, Gilberto S.;Bawn, Carlo M.;Maxwell, Ross J.
通讯作者:
Maxwell, Ross J.